RESULTS
toxicity, Tumor, Toxicity
ONCOLOGY, TUMOR
All trial participants (n = 572) had data on time toxicity available and were included in the current analyses. The median age was 63 years, 64% of participants were men, and 77% had an Eastern Cooperative Oncology Group performance status of 0-1. Baseline characteristics were balanced between arms, and detailed data are available in prior publications.For the overall study population, median time toxic days were higher in the cetuximab arm (28, Time Toxicity Measures in CO.17 for the Overall Study PopulationResults stratified by Time Toxicity Measures in CO.17 Stratified by Tumor For patients with 